Both in Pharmaceuticals
Rani Therapeutics Holdings vs Telomir Pharmaceuticals
Over the past year RANI returned −74.3% and TELO returned −39.0%; their daily moves had a correlation of 0.19.
RANI −74.3% TELO −39.0%Growth of $1, one year, split-adjusted
| Metric | RANI | TELO |
|---|---|---|
| Price | $0.5518 | $0.9151 |
| Market cap | $63.7M | $67.4M |
| Today | −6.47% | −2.15% |
| 1 month | −31.9% | −22.4% |
| 6 months | −40.8% | −30.7% |
| Year to date | −59.1% | −31.2% |
| 1 year | −61.9% | −39.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −432.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.1× | — |
| Net cash | $53.4M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 63.3% | 46.5% |
| Short % of float | 10.4% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).